drugset / Trial / NCT00695032
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
Non-randomizedParallel-groupTreatment
Summary
RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is evaluating kidney damage in patients receiving cisplatin and ifosfamide for solid tumors.
Timeline
- Start
- 2007-10
- Primary completion
- 2012-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Ifosfamide | Small molecule | — | — |